Bal Pharma has informed that a meeting of the Board of Directors of the Company will be held on May 25, 2016, to take on record and approve the audited financial results of the Company for the financial year ended March 31, 2016; Appropriation of profits including recommendation of dividend, if any for the F.Y 2015-16; to consider various other A.G.M related aspects. As per the provisions of Bal Pharma Code of Conduct for prevention of insider trading, the trading window of the Company shall remain closed on all the specified persons of the Company, from May 13, 2016 and up to May 28, 2016.
The above information is a part of company’s filings submitted to BSE.
